FOXP1-AS1

Across TCGA pan-cancer cohorts, FOXP1-AS1 RNA differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of FOXP1-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where FOXP1-AS1 RNA is repressed in tumor relative to normal tissue. In most cancer types FOXP1-AS1 is over-expressed in tumor, although a few such as THCA and KIRC show the opposite, repressed pattern.

THCA, KIRC, and LUSC are the cancer types where FOXP1-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in FOXP1-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Female	All	−0.240	<.001	9	view →
KIRC	All	All	−0.066	<.001	6	view →
LUSC	Male	All	−0.234	<.001	4	view →
PRAD	All	All	+0.259	.012	2	view →
COAD	Male	All	+0.180	.025	2	view →
ESCA	Female	All	−0.710	.042	1	view →
KIRP	All	All	−0.075	.035	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

FOXP1-AS1–THCA

Open the THCA breakdown →